|
The American Society of Hematology (ASH) Meeting, December 5-9, 1997
This Conrad Notes report on the American Society of Hematology (ASH) Meeting presents succinct analysis of key presentations.
- Antiangiogenesis Therapy in Cancer - J. Folkman
- Does Low Molecular Weight Heparin Prolong Cancer Patient Survival? - A. Kakkar
- Total Therapy of Acute Myeloid Leukemia (AML) - R. Powles
- Idarubicin (IDA) for Older Non-Hodgkins Lymphoma Patients - F. Cabanillas
- Nutrition and Survival After Bone Marrow Transplant - M. E. Hill
- Trends in Blood Component Usage - M. A. Popovsky
- Who Should Pay for Basic Research and Clinical Trials? - J. Stossel
- CD34+ Cell Transplants Reduce Hospital Costs - J. Glaspy
The American Society of Hematology Meeting Report of Conrad Notes is supported by an unrestricted educational grant from Pharmacia & Upjohn.
©Copyright 1995-2012 Ultitech, Inc. All Rights Reserved.